[{"Assets_0_Q1_USD":"1228300000.0","CIK":"899923","CommonStockSharesIssued_0_Q1_shares":"69200000.0","CommonStockSharesOutstanding_0_Q1_shares":"69200000.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"1.18","EarningsPerShareDiluted_1_Q1_USD":"1.15","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","MinorityInterest_0_Q1_USD":"-300000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"23500000.0","NetIncomeLoss_1_Q1_USD":"81100000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_Q1_USD":"81000000.0","RevenuesConverted_1_Q1_USD":"190200000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"870600000.0","StockholdersEquity_0_Q1_USD":"870900000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"70400000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"68600000.0","filed":"20171108","footnote":null,"form":"10-Q","fp":"Q1","fy":"2018.0","name":"MYRIAD GENETICS INC","period":"20170930","qtrs":"0","uom":"USD"}]